研究了纳米羟基磷灰石(nano-HAP)颗粒肌肉注射后在小鼠体内的分布、蓄积和排泄,以了解nano-HAP是否具有体内迁移特性。试验分为nano-HAP和micro-HAP两组,分别将中子活化的nano-HAP和作为对照的微米羟基磷灰石(micro-HAP)经肌肉注射到小鼠体内,剂量为91 mg/kg。在1周、2周、4周、8周、12周、18周、24周时断髓处死动物,解剖并收集动物的血液、脑、心、肝、脾、肺、肾、胃、小肠、胸骨、子宫或睾丸、粪便和尿液。用高氯酸和双氧水将收集的样品消解后,通过液体闪烁计数器测定各脏器组织和排泄物中的45Ca ?射线计数来反映nano-HAP和micro-HAP在动物体内的分布。结果显示,肌肉注射nano-HAP后,大部分组织中45Ca ?射线计数范围为0-79 Counts×min-1×mg-1,注射micro-HAP后为0.0-25 Counts×min-1×mg-1。两种HAP颗粒在体内分布部位没有显著差异,说明nano-HAP颗粒不会以颗粒形态在体内迁移,不具有在体内迁移的生物特性。骨骼是nano-HAP和micro-HAP唯一的蓄积器官,整个试验期间,两组动物骨骼中的45Ca ?射线计数变化不大,但nano-HAP组骨骼中的45Ca ?射线计数显著高于micro-HAP组。这说明nano-HAP具有比micro-HAP更好的骨结合和骨诱导性。
The present study was designed to investigate the distribution, accumulation and excretion of hydroxylapatite nanoparticles (nano-HAP)in mice with intramuscular administration. Mice were injected at 91 mg/kg with either nano-HAP or hydroxylapatite microparticles (micro-HAP) activated by neutrons, and then sacrificed at 1, 2 , 4 , 8, 12, 18, 24 week for getting samples, respectively. The main organs of the experimental animals were harvested for digestion, and then the counts of 45Ca in every sample were measured by a liquid scintillation counter. The results indicated that 0–79 counts×min-1×mg-1 45Ca could be detected in all main organs after nano-HAP injection and 0–25 counts×min-1×mg-1 after micro-HAP injection. There were no significant differences between the SNP group and SMP group (p>0.05) in the distribution in vivo. Bone is the only tissue for accumulation of nano-HAP and micro-HAP. Compared with micro-HAP, a larger amount of nano-HAP accumulated in bone. The results suggest that nano-HAP have a better osseointegration and bone inductivity.Cited
纳米羟基磷灰石颗粒体内分布中子活化小鼠
Hydroxylapatite nanoparticleDistributionNeutron activationMice
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构